Elite Pharmaceuticals Expands Board of Directors with Election of Aqeel A. Fatmi, Ph.D., and John W. LaRocca, Esq.
Northvale, New Jersey--(Newsfile Corp. - November 3, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced today that on October 28, 2026, its Board of Directors (the "Board") increased the size of the Board from four to six directors and unanimously elected Aqeel A. Fatmi, Ph.D., and John W. LaRocca, Esq. as directors. "We are pleased to welcome Aqeel Fatmi and John LaRocca to our Board of...